Damon Groenveld - Global Health Principal Architect
| GLH Stock | 0.14 0.01 6.67% |
Executive
Damon Groenveld is Principal Architect of Global Health
| Address | 696 Bourke Street, Melbourne, VIC, Australia, 3000 |
| Phone | 61 3 9675 0600 |
| Web | https://www.global-health.com |
Global Health Management Efficiency
The company has return on total asset (ROA) of (0.2472) % which means that it has lost $0.2472 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (13.5875) %, meaning that it generated substantial loss on money invested by shareholders. Global Health's management efficiency ratios could be used to measure how well Global Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Global Health's Liabilities And Stockholders Equity is comparatively stable compared to the past year. Non Current Liabilities Total is likely to gain to about 1 M in 2025, whereas Total Current Liabilities is likely to drop slightly above 3.6 M in 2025.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Rebekah Hourigan | Charter Hall Retail | N/A | |
| AAPI DipVal | Charter Hall Retail | N/A | |
| Philip Cheetham | Charter Hall Retail | N/A | |
| Michael Curtis | 4Dmedical | N/A | |
| Darragh Lyons | Oneview Healthcare PLC | 44 | |
| Matt Tucker | 4Dmedical | N/A | |
| John Kelly | Oneview Healthcare PLC | N/A | |
| Aidan BE | 4Dmedical | N/A | |
| Beth Plunkett | 4Dmedical | N/A | |
| David Harrison | Charter Hall Retail | 59 | |
| Colin Hackwood | Oneview Healthcare PLC | N/A | |
| JP Howe | Oneview Healthcare PLC | N/A | |
| Simon Glover | 4Dmedical | N/A | |
| Toni Pettit | Oneview Healthcare PLC | N/A | |
| Rachael Tenkaten | 4Dmedical | N/A | |
| Naomi Lawrie | 4Dmedical | N/A | |
| Paul BA | 4Dmedical | N/A | |
| Joanne Donovan | Charter Hall Retail | N/A | |
| Steven Bennett | Charter Hall Retail | N/A | |
| Mark Bryant | Charter Hall Retail | N/A | |
| MBA BS | 4Dmedical | N/A | |
Management Performance
| Return On Equity | -13.59 | ||||
| Return On Asset | -0.25 |
Global Health Leadership Team
Elected by the shareholders, the Global Health's board of directors comprises two types of representatives: Global Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Global. The board's role is to monitor Global Health's management team and ensure that shareholders' interests are well served. Global Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Global Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robin Armstrong, Regional Focus | ||
| Kye Cherian, Chief Officer | ||
| Jessica Moore, Vice Relations | ||
| BBus MAICD, Group Director | ||
| Deborah Hudson, Ma Group | ||
| James CPA, Company Secretary | ||
| Stuart Cronin, Chief Officer | ||
| Damon Groenveld, Principal Architect | ||
| Gareth Hooper, Chief Officer | ||
| LLB BE, Company Sec |
Global Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Global Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -13.59 | ||||
| Return On Asset | -0.25 | ||||
| Profit Margin | (0.15) % | ||||
| Operating Margin | (0.03) % | ||||
| Current Valuation | 7.09 M | ||||
| Shares Outstanding | 58.05 M | ||||
| Shares Owned By Insiders | 79.71 % | ||||
| Shares Owned By Institutions | 0.82 % | ||||
| Price To Book | 2.66 X | ||||
| Price To Sales | 0.94 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Global Stock Analysis
When running Global Health's price analysis, check to measure Global Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Global Health is operating at the current time. Most of Global Health's value examination focuses on studying past and present price action to predict the probability of Global Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Global Health's price. Additionally, you may evaluate how the addition of Global Health to your portfolios can decrease your overall portfolio volatility.